Viewing Study NCT07313150


Ignite Creation Date: 2026-03-26 @ 3:15 PM
Ignite Modification Date: 2026-04-14 @ 12:23 PM
Study NCT ID: NCT07313150
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-31
First Post: 2025-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Trial of Subcutaneous QLS7305 in Healthy Adults
Sponsor: Qilu Pharmaceutical Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteers - Male and Female View
Keywords:

Keywords

Keyword Brief Keyword Text View
None QLS7305 View
None Double-stranded small interfering ribonucleic acid (siRNA) targeting complement View
None First-in-human View
None C3 View
None SAD View
None MAD View